Capital Fund Management (CFM)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Capital Fund Management (CFM)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,000	Closed	-$403K	–	2189
2018 Q4	$403K	Sell	4,000 -300	-7%	-$31.1K	﹤0.01%	1478
2018 Q3	$543K	Buy	+4,300	New	+$455K	﹤0.01%	1566
2018 Q2	–	Sell	-4,000	Closed	-$246K	–	2345
2018 Q1	$246K	Sell	4,000 -6,300	-61%	-$380K	﹤0.01%	1698
2017 Q4	$602K	Buy	+10,300	New	+$650K	﹤0.01%	1391
2017 Q1	–	Sell	-8,300	Closed	-$902K	–	1920
2016 Q4	$902K	Buy	+8,300	New	+$989K	0.01%	1049
2015 Q3	–	Sell	-1,200	Closed	-$290K	–	1733
2015 Q2	$290K	Buy	+1,200	New	+$320K	﹤0.01%	1280

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s ICPT Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2021, closing a stake of 19,683 shares — an estimated $393K sold.

Capital Fund Management (CFM) first reported a position in ICPT in Q2 2014 and held it in 13 quarters. The position peaked at $5.84M in Q2 2014. 139 funds tracked by Wall St. Rank hold ICPT as of Q3 2021.

Capital Fund Management (CFM) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Capital Fund Management (CFM) sold 19,683 Intercept Pharmaceuticals, Inc. shares in Q3 2021, an estimated $393K.
Capital Fund Management (CFM) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 13 quarters.
Capital Fund Management (CFM)'s Intercept Pharmaceuticals, Inc. position peaked at $5.84M in Q2 2014.
139 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.